Live webcast on Thursday December 17, 2020 on masitinib’s results in Alzheimer’s Disease
16/12/2020 – AB Science will host a live webcast on December 17, 2020 on masitinib results in Alzheimer’s Disease
Positive Phase 2/3 study AB09004 with masitinib in Alzheimer’s Disease
16/12/2020 – AB Science announces that Phase 2B/3 study evaluating masitinib in Alzheimer’s disease met its primary endpoint